Adding blood flow restriction to physical therapy for adolescents with spasmodic rigid flatfoot
Official title: Does Adding Blood Flow Restriction Training to the Physical Therapy Program Improve Outcomes in Adolescents With Spasmodic Flatfoot Deformity?
Run by Assiut University · NCT07343752 · Data updated 2026-11-12
This trial will test whether adding blood flow restriction (BFR) training to physical therapy helps adolescents with spasmodic rigid flatfoot do better than standard physical therapy alone.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 10 Years to 18 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Assiut University Academic / other |
| Locations | 1 site (Asyut) |
| Status | Recruiting |
| Started | August 18, 2025 |
| Main results expected | August 2026 |
| Study ends | December 2026 |
| Registry record updated | January 15, 2026 |
| Trial ID | NCT07343752 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adolescents younger than 18 with idiopathic, rigid, spasmodic flatfoot who did not improve after three weeks of medical treatment and who can attend in-person follow-up without having neurological disorders or generalized tarsal arthritis are ideal candidates.
✕Probably not a fit
Patients with secondary rigid flatfoot deformity, generalized tarsal arthritis, neurological disorders, those who refuse participation, or those unable to complete follow-up are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized clinical trial enrolls adolescents under 18 with idiopathic, rigid, spasmodic flatfeet who did not respond to three weeks of initial medical treatment. Participants are randomized to a physical therapy program that either includes blood flow restriction (BFR) training or follows the same protocol without BFR. Outcomes will include pain, foot function, muscle strength, and gait measures collected through scheduled follow-up visits and standardized evaluations. All treatments and assessments are performed in-person at the Physical Therapy Unit of Assiut University Hospital.
Why it matters
Potential benefit: If successful, adding BFR could speed muscle strength gains and improve foot function and pain control beyond what standard physical therapy achieves.
How similar studies have gone: BFR has shown success for improving muscle strength and function in adults and some pediatric populations, but its use specifically for spasmodic rigid flatfoot in adolescents is novel and not well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adolescents presented with idiopathic, rigid, spasmodic flatfeet. * Age should be younger than 18 years old. 3- Patients who did not respond to initial medical treatment for three weeks. Exclusion Criteria: * generalised tarsal arthritis * neurological disorder. * secondary rigid flatfoot deformity * patients who did not complete the follow up or evaluation protocol * Patients who will refuse to participate
Where it's running
-
Assiut University Hospital, Physical Therapy Unit
Asyut, Egypt Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using a sinus tarsi implant to improve surgery for flatfoot deformity
This study is testing if a new implant can help improve surgery results for adults with flatfoot deformity by providing better support and alignment.
-
Oral Gabapentin vs IV Neostigmine/Atropine vs Both for Preventing PDPH
This study tests whether taking gabapentin by mouth, getting neostigmine with atropine by IV, or using both can help prevent postdural puncture headache after spinal anesthesia in pregnant patients.
-
Predicting Heart Muscle Recovery After CTO Revascularization
This study looks at whether blood tests and stress echo measurements can predict which patients with CTO will regain heart muscle function after a revascularization procedure.
-
Lower-dose induction for pediatric AML with G-CSF support
This study tests a lower-dose induction regimen with G-CSF in children with de novo acute myeloid leukemia to see if it lowers early toxicity without hurting survival.
-
Change in Fat Content of Bone Metastases After Treatment
This study tests if a special MRI method can see early changes in bone metastases by measuring fat content before and after chemotherapy or radiotherapy in adults.
-
Health education to see if primigravida women choose vaginal delivery more often
A health education program is being tested to see if it helps first-time pregnant women in choosing vaginal delivery over unnecessary cesareans.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.